Amiodarone Hydrochloride is primarily used in the treatment of various types of cardiac arrhythmias, including ventricular fibrillation and ventricular tachycardia. It is particularly effective in cases where other antiarrhythmic drugs have failed. The medication works by prolonging the action potential and refractory period in cardiac tissues, thereby stabilizing the heart rhythm. In clinical settings, it is often administered intravenously for rapid control of life-threatening arrhythmias or orally for long-term management. Due to its potent effects, it is commonly used in patients with severe heart conditions, such as those with congestive heart failure or after myocardial infarction. However, its use requires careful monitoring due to potential side effects, including pulmonary toxicity, liver damage, and thyroid dysfunction. Despite these risks, Amiodarone Hydrochloride remains a critical tool in managing complex arrhythmias, especially in patients with structural heart disease.